Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Sanofi”
Sponsor: European Society for Blood and Marrow Transplantation
Aplastic Anemia
France, Germany, Italy, Saudi Arabia, Switzerland +1 more
- A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)Not Yet Recruiting
Sponsor: Sanofi
Chronic Graft Versus Host Disease
- Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in ChinaActive Not Recruiting
Sponsor: Sanofi
Meningococcal Infection · Healthy Volunteers
China
- Efficacy and Safety of NVX-CoV2705Active Not Recruiting
Sponsor: Novavax
COVID-19 · Sars-CoV-2 Infection
United States
Sponsor: Sanofi
Respiratory Syncytial Virus (RSV) · Influenza A(H5N1)
Australia
Sponsor: Sanofi
Yellow Fever Immunization
Honduras, Mexico, Panama
- A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal PolypsActive Not Recruiting
Sponsor: Sanofi
Chronic Rhinosinusitis Without Nasal Polyps
United States, Argentina, Belgium, Canada, Chile +8 more
Sponsor: Sanofi
COVID-19 Immunization · Influenza Immunization
United States
Sponsor: Sanofi
COVID-19 Immunization · Influenza Immunization
United States
Sponsor: Sanofi
Plasma Cell Myeloma
United States, Australia, Belgium, China, Czechia +16 more
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
South Africa
Sponsor: Sanofi
Chlamydia Trachomatis
Germany
- Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple MyelomaActive Not Recruiting
Sponsor: Poitiers University Hospital
Multiple Myeloma · Myeloma Multiple · Myeloma
France
- Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMMActive Not Recruiting
Sponsor: Jacob Laubach, MD
Multiple Myeloma · Newly Diagnosed Multiple Myeloma (NDMM) · Autologous Stem Cell Transplant
United States
Sponsor: University Hospital, Toulouse
Multiple Myeloma
France
- Dupilumab for Eosinophilic Esophagitis With Severe StricturesActive Not Recruiting
Sponsor: University of North Carolina, Chapel Hill
Eosinophilic Esophagitis · EoE
United States
Sponsor: Sanofi
Chronic Rhinosinusitis With Nasal Polyps
United States, Argentina, Belgium, Bulgaria, Poland +1 more
Sponsor: Sanofi
Respiratory Syncytial Virus Immunization
Australia
Sponsor: Sanofi
Epilepsy · Seizures
France
- Dose-finding Study of SAR443122 in Adult Participants With Ulcerative ColitisActive Not Recruiting
Sponsor: Sanofi
Colitis Ulcerative
United States, Argentina, Chile, China, Czechia +14 more
Sponsor: Won Seog Kim
Natural Killer/T-cell Lymphoma · Relapsed Natural Killer/T-cell Lymphoma · Refractory Natural Killer/T-cell Lymphoma
South Korea
Sponsor: European Society for Blood and Marrow Transplantation
Aplastic Anaemia
Czechia, France, Germany, Greece, Italy +4 more
Sponsor: Sanofi
Dermatitis Atopic
Germany
Sponsor: Sanofi
Ulcerative Colitis
United States, Australia, China, Czechia, France +7 more
- Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic DermatitisActive Not Recruiting
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Australia, Brazil, Canada +20 more